drugset / Trial / NCT04203537
Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 (Vocacapsaicin)
RandomizedSequentialQuadruple-blindTreatment
Summary
In the pilot (Part A) of this study, multiple doses of CA-008 (vocacapsaicin) were evaluated for safety, tolerability, and PK. Doses were then selected for the expanded part (Part B) of the study, where CA-008 was compared to placebo. Patients had serial assessments of safety, PK, and drug effect.
Timeline
- Start
- 2019-12-04
- Primary completion
- 2020-10-26
- Completion
- 2020-10-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | vocacapsaicin | Small molecule | 36 mg | Other |
| Comparator | vocacapsaicin | Small molecule | 60 mg | Other |
| Comparator | vocacapsaicin | Small molecule | 90 mg | Other |
Indications
No indication recorded.